138 related articles for article (PubMed ID: 7308253)
1. Evaluation of intratumoral immunostimulants in the treatment of a transplantable rat mammary carcinoma.
Willmott N; Austin EB; Pimm MV; Baldwin RW
Eur J Cancer (1965); 1981 Apr; 17(4):397-405. PubMed ID: 7308253
[No Abstract] [Full Text] [Related]
2. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
Greager JA; Baldwin RW
Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
[No Abstract] [Full Text] [Related]
3. Inhibition or enhancement of rat mammary tumors dependent on dose BCG.
Piessens WF; Campbell M; Churchill WH
J Natl Cancer Inst; 1977 Jul; 59(1):207-11. PubMed ID: 875054
[TBL] [Abstract][Full Text] [Related]
4. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
Wolmark N; Fisher B
Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
[No Abstract] [Full Text] [Related]
5. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
6. Effect of BCG treatment on the evolution of cell-mediated immunity in mice bearing transplantable syngeneic tumors.
Youn JK; Francois DL; Santillana M; Hue G; Barski G
Eur J Cancer (1965); 1977 Feb; 13(2):177-86. PubMed ID: 852489
[No Abstract] [Full Text] [Related]
7. [Growth of transplantable aflatoxin B1-induced mammary cancer in Wistar rats during treatment with BCG vaccine].
Leszczyszyn J
Patol Pol; 1986; 37(3):222-36. PubMed ID: 3104870
[No Abstract] [Full Text] [Related]
8. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
9. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Mathe G
Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350
[No Abstract] [Full Text] [Related]
10. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
Kreider JW; Bartlett GL; Purnell DM
J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
[TBL] [Abstract][Full Text] [Related]
11. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
Haskill S; Ritter F; Becker S
J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
[No Abstract] [Full Text] [Related]
12. The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
El Kappany H; Chopra C; Nigam VN; Brailovsky CA; Elhilali M
Br J Cancer; 1980 Nov; 42(5):703-11. PubMed ID: 7459208
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
14. [Experimental studies on the treatment and prophylaxis of cancer by immunoactivators and interferon].
Kitasato M
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1472-80. PubMed ID: 6440934
[No Abstract] [Full Text] [Related]
15. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
16. BCG immunotherapy of rat tumours in athymic nude mice.
Pimm MV; Baldwin RW
Nature; 1975 Mar; 254(5495):77-8. PubMed ID: 234599
[No Abstract] [Full Text] [Related]
17. [First clinical trials of treatment of primary liver cancer with immunostimulating agents administered by systemic or intratumoral route].
Tung TT; Bang NH; Van Ton NV; Bach T; Tam ND; Salomon JC
Chirurgie; 1975 Jun 11-25; 101(8):542-5. PubMed ID: 170046
[No Abstract] [Full Text] [Related]
18. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
Fisher B; Gebhardt M; Linta J; Saffer E
Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
[No Abstract] [Full Text] [Related]
19. Immune adjuvant therapy in lung cancer.
Holmes EC
Prog Exp Tumor Res; 1980; 25():229-41. PubMed ID: 6986634
[No Abstract] [Full Text] [Related]
20. Active experimental inhibition of cancer by corynebacterium parvum.
Wrba H; Dutter A
Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
